StockStory.org on MSN5h
Beyond Meat (NASDAQ:BYND) Exceeds Q4 ExpectationsPlant-based protein company Beyond Meat (NASDAQ:BYND) announced in Q4 CY2024, with sales up 4% year on year to $76.66 million ...
Hosted on MSN4h
SunOpta (NASDAQ:STKL) Posts Q4 Sales In Line With EstimatesPlant-based food and beverage company SunOpta (NASDAQ:STKL) in Q4 CY2024, with sales up 6.8% year on year to $193.9 million.
Biotech giant Renegeron Pharmaceuticals (NASDAQ: REGN) reported its fourth-quarter and full-year 2024 earnings on Feb. 4. The company's results were strong, coming in ahead of analyst estimates.
1d
Investing News Network on MSNStem Cell Stocks: 10 Biggest NASDAQ Companies in 2025Stem cell research and regenerative medicine are growing markets in the life science sector, and the top stem cell companies ...
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) in Q4 CY2024, with sales up 35% year on year to $282.6 million ...
Palantir Technology's (NASDAQ: PLTR) stock has been nearly unstoppable ... That shows that both the underlying company and the market opportunity are strong. Although Palantir attained a $236 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results